Form4insider filings, from the source

SEC Form 4 · accession 0001104659-18-073392

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mary Z. Luo
Officer — COO,Chief Scientist & Chairman · Director · 10% Owner
Jack Y. Zhang
Officer — CEO & Chief Scientific Officer · Director · 10% Owner
Period of report
Dec 14, 2018
Accepted (ET)
Dec 17, 2018 · 8:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 14, 2018S43,577$20.4766D2,072,317D
Common StockF2holding———1,366,706ISee footnote
Common StockF3holding———7,327,679ISee footnote
Common StockF4holding———5,000ISee footnote
Common StockF5holding———200,000ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses